Chemi Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-07-2024
- Paid Up Capital ₹ 0.10 M
as on 05-07-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -17.61%
(FY 2021)
- Profit -21.24%
(FY 2021)
- Ebitda -18.72%
(FY 2021)
- Net Worth 18.17%
(FY 2021)
- Total Assets 4.69%
(FY 2021)
About Chemi Pharma Distributors
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhushan Kumar and Komal Singh serve as directors at the Company.
- CIN/LLPIN
U52310WB2010PTC153879
- Company No.
153879
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chemi Pharma Distributors?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Komal Singh | Director | 09-Mar-2019 | Current |
Bhushan Kumar | Director | 20-Mar-2019 | Current |
Financial Performance and Corporate Structure Insights of Chemi Pharma Distributors.
Chemi Pharma Distributors Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 17.61% decrease. The company also saw a substantial fall in profitability, with a 21.24% decrease in profit. The company's net worth Soared by an impressive increase of 18.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Chemi Pharma Distributors?
In 2020, Chemi Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Squad Minds Management Private LimitedActive 5 years 1 day
Bhushan Kumar and Komal Singh are mutual person
- Shri Ganpati Rice Mill And Rice Bran Industries Private LimitedActive 11 years 10 months
Komal Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemi Pharma Distributors?
Unlock and access historical data on people associated with Chemi Pharma Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemi Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemi Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.